Journal
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Volume 12, Issue 2, Pages E1154-E1163Publisher
WILEY
DOI: 10.1002/term.2450
Keywords
chronic spinal cord injury; collagen; functional recovery; human umbilical cord-derived mesenchymal stem cell; neural regeneration; surgical scar resection
Categories
Funding
- Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01030000]
- Key Research Program of the Chinese Academy of Sciences [ZDRW-ZS-2016-2]
Ask authors/readers for more resources
Effective therapeutic strategies for treating chronic spinal cord injury (SCI) are currently unavailable. Scar tissue in the lesion area is a main inhibitory factor for axonal regeneration and repair of chronic SCI. In this study, scar tissue was surgically resected from adult rats with 12week chronic SCI and then collagen scaffold (NeuroRegen Scaffold; NRS) and human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) were implanted into the resected cavity to repair chronic SCI. The results demonstrated that the locomotor function of rats was not affected by surgical scar resection, indicating its safety in treating chronic SCI. Implanting NRS and hUC-MSCs promoted locomotion in rats and improved cortical motor- and somatosensory-evoked potentials. Furthermore, implanting NRS and hUC-MSCs promoted neurofilament- and -tubulin-III-positive neural regeneration and remyelination, elicited -tubulin-III-positive neuron production in the lesion area and blocked astrocyte growth outside the lesion area. In conclusion, implanting NRS in combination with hUC-MSCs provided a beneficial microenvironment for neural regeneration, showing significant therapeutic effects for chronic SCI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available